Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$654.9K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 21 most recent Form 4 transactions.
| $73.3K |
| -2.9% |
| Open the original filing on SEC.gov |
| Jul 24 | ORIC | Oric Pharmaceuticals, Inc. | SSELL◷ | 7,000 | $12.02 | $84.1K | -15.4% | Open the original filing on SEC.gov |
| Jul 24 | ORIC | Oric Pharmaceuticals, Inc. | MEXER◷ | 3,500 | $1.60 | $5.6K | +8.4% | Open the original filing on SEC.gov |
| Jul 6 | ORIC | Oric Pharmaceuticals, Inc. | SSELL◷ | 300 | $12.00 | $3.6K | -0.1% | Open the original filing on SEC.gov |
| Feb 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 1,230 | $26.18 | $32.2K | -5.1% | Open the original filing on SEC.gov |
| Feb 12 | ELVN | Enliven Therapeutics, Inc. | AGRANT◆ | 19,234 | — | — | — | Open the original filing on SEC.gov |
| Jan 20 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 718 | $26.96 | $19.4K | -2.9% | Open the original filing on SEC.gov |
| Jan 20 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 512 | $26.46 | $13.5K | -2.0% | Open the original filing on SEC.gov |
| Jan 16 | ORIC | Oric Pharmaceuticals, Inc. | SSELL◷ | 3,200 | $12.00 | $38.4K | -1.5% | Open the original filing on SEC.gov |
| Jan 16 | ORIC | Oric Pharmaceuticals, Inc. | SSELL◷ | 3,500 | $12.00 | $42K | -7.7% | Open the original filing on SEC.gov |
| Jan 9 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 4,285 | $25.00 | $107.1K | -14.6% | Open the original filing on SEC.gov |
| Jan 8 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 8,015 | $25.04 | $200.7K | -21.4% | Open the original filing on SEC.gov |
| Jan 8 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 1,620 | $25.00 | $40.5K | -6.0% | Open the original filing on SEC.gov |
| Jan 2 | ORIC | Oric Pharmaceuticals, Inc. | AGRANT◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 3, 2025 | ORIC | Oric Pharmaceuticals, Inc. | MEXER◆ | 1,447 | — | — | — | Open the original filing on SEC.gov |
| Oct 3, 2025 | ORIC | Oric Pharmaceuticals, Inc. | MEXER◆ | 18,125 | — | — | — | Open the original filing on SEC.gov |
| Oct 3, 2025 | ORIC | Oric Pharmaceuticals, Inc. | MEXER◆ | 13,228 | — | — | — | Open the original filing on SEC.gov |
| Oct 3, 2025 | ORIC | Oric Pharmaceuticals, Inc. | MEXER | 1,447 | $3.75 | $5.4K | +3.3% | Open the original filing on SEC.gov |
| Oct 3, 2025 | ORIC | Oric Pharmaceuticals, Inc. | MEXER | 31,353 | $1.60 | $50.2K | +250.8% | Open the original filing on SEC.gov |
| Jun 5, 2025 | PMVP | PMV Pharmaceuticals, Inc. | AGRANT◆ | 33,500 | — | — | — | Open the original filing on SEC.gov |